These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 19492955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW, Ward KW.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH, Fung HB.
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [Abstract] [Full Text] [Related]

  • 7. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
    Donnenfeld ED, Comstock TL, Proksch JW.
    J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
    [Abstract] [Full Text] [Related]

  • 8. Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.
    Amar T, Caillaud T, Elena PP.
    Curr Eye Res; 2008 Feb; 33(2):149-58. PubMed ID: 18293185
    [Abstract] [Full Text] [Related]

  • 9. A novel, sensitive, and widely accessible besifloxacin quantification method by HPLC-fluorescence: Application to an ocular pharmacokinetic study.
    Kuang L, Ross AE, Kanu LN, Romanowski EG, Kowalski RP, Kohane DS, Ciolino JB.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov 15; 1185():123010. PubMed ID: 34731742
    [Abstract] [Full Text] [Related]

  • 10. Besifloxacin ophthalmic suspension for bacterial conjunctivitis.
    Nafziger AN, Bertino JS.
    Drugs Today (Barc); 2009 Aug 15; 45(8):577-88. PubMed ID: 19927224
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
    Glogowski S, Lowe E, Siou-Mermet R, Ong T, Richardson M.
    J Ocul Pharmacol Ther; 2014 Feb 15; 30(1):66-73. PubMed ID: 24325539
    [Abstract] [Full Text] [Related]

  • 15. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P, Depaolis M, Hunter JA, White EM, Rigel L, Brunner LS, Usner DW, Paterno MR, Comstock TL.
    Clin Ther; 2009 Mar 15; 31(3):514-26. PubMed ID: 19393842
    [Abstract] [Full Text] [Related]

  • 16. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J, Jones RN, Bertino JS.
    J Ocul Pharmacol Ther; 2012 Feb 15; 28(1):3-11. PubMed ID: 21999341
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE, Allaire C, Bateman KM, Gearinger LS, Morris TW, Comstock TL.
    Clin Ther; 2011 Jan 15; 33(1):13-26. PubMed ID: 21397770
    [Abstract] [Full Text] [Related]

  • 18. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C, Melilli B, Piazza C, Zurria M, Drago F.
    J Ocul Pharmacol Ther; 2011 Dec 15; 27(6):571-6. PubMed ID: 22059858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.